SYNTELLIX - FROM A START-UP TO
Although still a very young company, Syntellix won the "German Industry Innovation Prize" in 2013. This "First Innovation Prize in the World®" has been awarded since 1980 every year to the most significant scientific, technical, commercial and intellectual innovations coming from German industry. The prize is awarded on behalf of the Federal German Ministry for Education and Research, as well as the Federal German Ministry for Economic Affairs and Energy.
Research and development work had been under way around the world for many years in the attempt to find a solution for bioabsorbable materials. Syntellix achieved the breakthrough after only five years. The recipe for success: establishing an interdisciplinary network with outstanding scientists at different research locations, combined with the entrepreneurial courage of the business people involved. In 2013, Syntellix gained the first CE approval world-wide for a biotransformable metallic implant. The jury for the German Industry Innovation Prize considered this performance to be worthy of a prize, and selected the company for the award in the start-up business category.
Various media reports on Syntellix and the innovation prize for the company are available here.
SYNTELLIX AG as TOP INNOVATOR in 2015 and 2016
In 2015, Syntellix won the coveted "Top-Innovator" award of the German Medium-sized Enterprise Association for extraordinary innovation strength and above average innovation success in a medium-sized enterprise. The award has been made since 1993 under the scientific management of Prof. Dr. Nikolaus Franke of the Institute for Entrepreneurship and Innovation at the Economics University in Vienna.
Syntellix won the award for the successful development and market launch of MAGNEZIX®. The jury particularly praised here the potential of the company with a high class team capable of turning outstanding scientific results into marketable products. With the MAGNEZIX® magnesium alloy, Syntellix AG has succeeded in producing a real innovation: this alloy resorbs in a controlled manner after the operation, is transformed into bone tissue, and therefore saves patients the stress and worry of having to undergo a second operation to remove the implant.
The jury formulated their judgement as follows: "A management team is primarily successful when it brings together different strengths and abilities to create an even better whole. This is important because it can then achieve more than the pure sum of each of the individual competencies. This is demonstrated precisely by the interdisciplinary innovation team at Syntellix AG. Three well-known experts in medicine, materials science and management came together in 2008 to create a disruptive innovation: a magnesium alloy for medical products which makes titanium screws superfluous."
Syntellix was again awarded the "Top-Innovator" award in 2016 to again demonstrate the innovation strength of the company.
Winner of the German Healthcare Future Prize 2016
The "Future Prize of the Health Industry" is awarded annually by the Club of the Health Industry in Berlin. It is worth € 10,000.00.
The Future Prize is awarded with the aim of providing a forum for innovations in all sectors of the health industry, and to raise awareness of these innovations amongst a high class circle of experts from hospitals, industry, media and services. The cdgw presiding committee chooses the candidates for the competition on the basis of the submitted abstracts. The criteria on which the prize is awarded primarily include originality, creativity, network character, practicability, patient and/or customer benefits, social relevance, and the cost-efficiency of projects or products.
These are precisely the factors which have been motivating the development and continuous optimisation of MAGNEZIX®: a metallic and at the same time biotransformable implant that saves patients the pain, suffering and risks of a second operation, makes available to doctors an innovative medical product with properties which favour healing during treatment, as well as saving the health and social systems money.
A pair of video spectacles with which patients can watch films during an operation (local anaesthetic) or chemotherapy, and screws and pins which can be completely resorbed within the body -- these two innovations were awarded the Future Prize of the Club of the Health Industry (cdgw) in Berlin.
ONE STEP FURTHER: SYNTELLIX BECOMES INDUSTRY WINNER TECH IN THE “STEP AWARD” 2017
For the 12th time in a row, the STEP Award honoured outstanding growth companies from Germany, Austria and Switzerland.
As a prestigious company award for industries of the future, the award is intended to reward the innovative strength of ambitious, up-and-coming companies in the sectors of science, technology and ICT and give them valuable impetus for their further development. Innovative, fast-growing (startup) companies make a significant contribution to a dynamic economy. The aim of the STEP Award is to promote companies and pioneers in future industries and give them important impulses for their successful development. The evaluation criteria of the STEP Award are based on the most important features of successful companies.
Applicants need to convince not only with their business idea and their management team, but also in the following dimensions:
FRANKFURT BUSINESS MEDIA GmbH - the "F.A.Z.-Fachverlag" is the initiator of the STEP Award. The 2017 competition was supported by well-known partners such as PricewaterhouseCoopers, AXA Group, Clariant, Infraserv Höchst, Sanofi-Aventis Germany and vertical.
FOCUS ON THE PATIENT: SYNTELLIX RECEIVES THE GERMAN MEDICAL AWARD FOR THE BEST PRODUCT INNOVATION IN 2017
The GERMAN MEDICAL AWARD, one of the few medical and management prizes awarded in Europe rewards innovative physicians, general practitioners, clinics and research projects that aim to sustainably improve patient care quality.
According to the mission statement, pioneers in medicine with excellent patient-centered expertise in medicine and management are to be encouraged on their path to abandon the conventional paradigms and to advocate innovative, personalized care for the benefit of the patient in an ever-faster-changing healthcare system.
The prize is awarded in several categories and presupposes the principles of medical ethics and the highest quality standards – doctors, practices, clinics and companies from the health sector, who have designed medical, technical, pharmaceutical and therapeutic innovations and products, as well as patient-oriented care solutions with exemplary function, and successfully implemented them, are rewarded.
The GERMAN MEDICAL AWARD is presented by a jury of experts, consisting of healthcare professionals such as clinic managers, lawyers and patient representatives, and supported by a panel of renowned physicians from various disciplines and economists. In particular, in addition to the experts, patients can also nominate nominees for the prize.
THE HIGHLIGHT OF 2017: SYNTELLIX IS HONOURED AS “INNOVATOR OF THE YEAR”
Together with mentor Ranga Yogeshwar, the TOP 100 jury - consisting of numerous well-known experts from business, science, media and politics - honours the most innovative companies in the German SME sector. The award is based on a comprehensive scientific survey and evaluation of entrepreneurial innovativeness by the Vienna University of Economics and Business. TOP 100 has been one of the most established and significant innovation awards in Germany for more than 25 years and is:
- The only competition that distinguishes innovation management
- The most important award for innovative companies in the SME sector
- The “Club of Excellence”, in which the German innovation elite gathers
“THIS IS A REALLY AMAZING MATERIAL WHICH OFFERS SO MANY ADVANTAGES IN USING IT THAT IS BOTH IMPRESSIVE AND OUTSTANDING.”
Edelgard Bulmahn (Vice-President of the German Bundestag)
“THIS INNOVATION HAS DISRUPTION POTENTIAL, EVEN AT A GLOBAL SCALE.”
Prof. Dr. Nikolaus Franke (Vienna University of Economics and Business)
Syntellix at the award ceremony (from left to right): Prof. Dr. Martin H. Kirschner, Prof. Dr. Utz Claassen, Mentor Ranga Yogeshwar, Thomas Mayer, Prof. Dr.-Ing. Volkmar Neubert
SYNTELLIX AG AWARDED FOR GLOBAL SUSTAINABILITY LEADERSHIP
In 2018, the Business Intelligence Group named Syntellix’ innovative magnesium technology MAGNEZIX® the “Sustainability Product of the Year” in the 2018 Sustainability Awards program.
The Sustainability Awards honor those people, teams and organizations who have made sustainability an integral part of their business practice or overall mission.
- The Sustainability Awards program provides the opportunity for organizations to receive global recognition by a panel of volunteer judges who themselves are leaders and experts in business.
"WE ARE PROUD TO REWARD AND RECOGNIZE SYNTELLIX AG FOR THEIR SUSTAINABILITY EFFORTS AND IT WAS CLEAR TO OUR JUDGES THAT THEIR VISION AND STRATEGY WILL CONTINUE TO DELIVER RESULTS TOWARD A CLEANER, MORE SUSTAINABLE WORLD. CONGRATULATIONS!” (Maria Jimenez, Chief Nominations Officer of the Business Intelligence Group)
MAGENZIX® PIN WINS GERMAN INNOVATION AWARD IN GOLD
With its German Innovation Award, the German Design Council, which was founded in 1953 on the initiative of the German Federal Parliament, honours trend-setting innovations that have a lasting effect and offer the user added value.
Syntellix AG was one of the evening’s winners: the highly innovative medical technology company from Hanover convinced the jury with its MAGNEZIX® Pins magnesium implants, for which it was awarded the German Innovation Award in Gold in the category Excellence in Business to Business – Medical Technologies.
There were 695 innovation candidates in total, including industry giants such as Samsung, Bosch, Deutsche Telekom and the Swiss group ABB, as well as hidden champions and start-ups.
- Award from the German Design Council evaluates the level of innovation, user benefits and costeffectiveness of products and services.
- Jury of experts selects award winners, judging MAGNEZIX® Pin as a “quantum leap in implantology”.
- German Innovation Award confirms Syntellix’s technology leadership and user orientation.
“THE GERMAN INNOVATION AWARD MEANS A GREAT HONOUR AND A GREAT OBLIGATION FOR US. WE SEE IT AS A FURTHER CONFIRMATION THAT OUR MAGNESIUM TECHNOLOGY HAS THE POTENTIAL TO REPLACE CONVENTIONAL TITANIUM, STEEL OR POLYMER IMPLANTS IN THE LONG TERM.”
Prof. Dr. Utz Claassen, CEO von Syntellix
Syntellix wins the Edison Award 2020 in silver
The 2020 Edison Awards winners were announced and Syntellix’s MAGNEZIX® CSc 4.8 took the silver award for the Medical/Dental category.
Among the nomination entries comprising the best products, services, and businesses in innovation for the year 2020, MAGNEZIX® CSc 4.8 was chosen as a winner by a panel of over 3,000 leading business executives in the fields of science, technology, design, engineering and marketing from around the world. “After a thorough review, the Edison Awards Judges recognize MAGNEZIX® as a game-changing innovation standing out among the best new products and services launched in their category,” said Frank Bonafilia, Executive Director of the Edison Awards.
- Since 1987, Edison Awards™ is an annual competition honoring excellence in new product and service development, human-centered design and innovation.
SYNTELLIX WINS IMA AWARD OF EXCELLENCE
Syntellix AG, together with its completely owned materials specialist subsidiary MSE (Materials Science and Engineering Werkstoffzentrum Clausthal GmbH), has been honored with the highly renowned 2020 Award of Excellence presented by the International Magnesium Association (IMA), Saint Paul/Minnesota.
Established in 1962, IMA's Awards of Excellence program is an annual program open to companies demonstrating outstanding examples of the use of magnesium. Nominations are judged by a peer-review panel of international experts, based on the criteria of innovation, technology, impact, synergies, competitive material displacement, and economics.
Syntellix has been appointed prize winner in the category “Wrought Product” for the development of its innovative magnesium-based MAGNEZIX® implant portfolio.
"EUROPEAN ENTREPRENEURIAL COMPANY OF THE YEAR" 2020
Internationally renowned and globally leading market research firm Frost & Sullivan presents Syntellix with this year’s Best Practices Entrepreneurial Company of the Year Award in the European orthopaedic and trauma implants industry.
According to the detailed analytic report, Frost & Sullivan research has confirmed Syntellix’s outstanding performance in many of the criteria examined, underlining its leading position in the orthopaedic and trauma implants space to further disrupt the medical device industry.
The report also sets forth that the future of medtech is shaped by three key strategic imperatives: disruptive technologies, innovative business models, and transformative megatrends – dimensions in which Syntellix is performing very well.
SYNTELLIX IS RECOGNIZED AS “COMPANY OF THE YEAR” 2020
Syntellix AG has officially been named “Company of the Year”, leading the list of “Top 10 Orthopedic Solution Providers in Europe” of the industry magazine and news platform MedTech Outlook in 2020.
MedTech Outlook (www.medicaltechoutlook.com) bridges the spectrum between medical technology providers and healthcare facilities and aims to assist decision makers to find the right solutions by annually compiling the top 10 best-in-class orthopaedic solution providers that exhibit innovative technologies and strategies.
Among those selected companies, the distinctive award panel has elected Syntellix as 2020 “Company of the Year” to appreciate the potentially life-saving use of MAGNEZIX implants during the COVID-19 pandemic.